Texas 2025 89th Regular

Texas Senate Bill SB623 Introduced / Fiscal Note

Filed 12/16/2024

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION             April 14, 2025       TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB623 by Schwertner (Relating to the authority of a pharmacist to determine whether to administer a vaccine, including a COVID-19 vaccine.), As Introduced     No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources.  Local Government ImpactNo significant fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 515 Board of Pharmacy  LBB Staff: b > td > JMc, NPe, GDZ, DPE

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
April 14, 2025



TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB623 by Schwertner (Relating to the authority of a pharmacist to determine whether to administer a vaccine, including a COVID-19 vaccine.), As Introduced

TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB623 by Schwertner (Relating to the authority of a pharmacist to determine whether to administer a vaccine, including a COVID-19 vaccine.), As Introduced



Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services

Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services

Jerry McGinty, Director, Legislative Budget Board

Jerry McGinty, Director, Legislative Budget Board

SB623 by Schwertner (Relating to the authority of a pharmacist to determine whether to administer a vaccine, including a COVID-19 vaccine.), As Introduced

SB623 by Schwertner (Relating to the authority of a pharmacist to determine whether to administer a vaccine, including a COVID-19 vaccine.), As Introduced

No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

It is assumed that any costs associated with the bill could be absorbed using existing resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 515 Board of Pharmacy



515 Board of Pharmacy

LBB Staff: b > td > JMc, NPe, GDZ, DPE



JMc, NPe, GDZ, DPE